Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2017 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Named to the Crain’s Chicago Business 2017 “Best Places To Work” List

DUBLIN, Ireland, April 07, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
March 30, 2017 07:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO® (naproxen/esomeprazole) Delayed Release Tablets

DUBLIN, Ireland, March 30, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
March 22, 2017 09:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc to Present Data on RAVICTI® (glycerol phenylbutyrate) Oral Liquid for Urea Cycle Disorder Patients Aged Two Months to Two Years

DUBLIN, Ireland, March 22, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
March 16, 2017 09:30 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces "UCD in Common" for the Urea Cycle Disorder (UCD) Community

DUBLIN, Ireland, March 16, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
March 02, 2017 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces Urea Cycle Disorders Medical Foods and Supplements Financial Assistance Program

DUBLIN, Ireland, March 02, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
February 28, 2017 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Launches RAREis™ Campaign Elevating Faces of the Rare Disease Community

DUBLIN, Ireland, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and...
February 27, 2017 07:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Full-Year 2017 Net Sales and Adjusted EBITDA Guidance

-- Fourth-Quarter 2016 Net Sales of $310.3 Million; Up 27 Percent ---- Fourth-Quarter 2016 Net Loss of $130.5 Million(1); Adjusted EBITDA of $136.4 Million -- -- Fourth-Quarter 2016 Operating Cash...
February 14, 2017 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference

DUBLIN, Ireland, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
January 27, 2017 08:00 ET | Source: Horizon Pharma plc

Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on February 27, 2017

DUBLIN, Ireland, Jan. 27, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...
December 22, 2016 16:05 ET | Source: Horizon Pharma plc

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid

DUBLIN, Ireland, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and...